Aptevo Therapeutics Inc. Unamortized Debt Issuance Expense
Aptevo Therapeutics Inc. (APVO) had Unamortized Debt Issuance Expense of $1.40 million as of 2017-12-31, per its 10-K filed 2018-03-13.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:UnamortizedDebtIssuanceExpense · last filed 2018-03-13
- 2017-12-31: Unamortized Debt Issuance Expense $1.40M.
- 2017-09-30: Unamortized Debt Issuance Expense $1.50M.
- 2017-06-30: Unamortized Debt Issuance Expense $1.50M.
- 2017-03-31: Unamortized Debt Issuance Expense $1.60M.
| Period end | Unamortized Debt Issuance Expense |
|---|---|
| 2017-12-31 | $1.40M 10-K · filed 2018-03-13 |
| 2017-09-30 | $1.50M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $1.50M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $1.60M 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |